Compugen to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference

Compugen, a clinical-stage cancer immunotherapy company using AI-powered computational target discovery, announced that management will participate in a fireside chat and conduct one-on-one meetings. The announcement contains no clinical data, financial results, guidance, partnership, or other material operating update.